DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (135)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 135   Next >>

Possible Dexamethasone side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL



Possible Dexamethasone side effects in female

Reported by a physician from France on 2012-08-21

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.82 milligram daily;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Rituximab
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Treanda
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Other drugs received by patient: Pegfilgrastim



Possible Dexamethasone side effects in female

Reported by a physician from France on 2012-08-21

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.82 milligram daily;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Rituximab
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Treanda
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Other drugs received by patient: Pegfilgrastim



Possible Dexamethasone side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: 68 year old female, weighing 88.0 kg (193.6 pounds)

Reactions: Dyspnoea, Pneumonia, Urinary Tract Infection, Constipation, Disease Progression, Multi-Organ Failure, Hypothyroidism, Gastrooesophageal Reflux Disease, Candidiasis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Crizotinib
    Dosage: 500 mg
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-07-26
    End date: 2011-08-16

Dexamethasone
    Dosage: 8 mg
    Administration route: Oral
    Indication: Palliative Care
    Start date: 2011-07-05

Other drugs received by patient: Calcium; Vicoprofen; Levothyroxine Sodium; Prochlorperazine; Omeprazole; Albuterol; Oxycontin; Ondansetron; Lactulose; Folic Acid; Atorvastatin; Colace; Clonazepam



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-08-16

Patient:

Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron



Possible Dexamethasone side effects in

Reported by a physician from Germany on 2012-08-09

Patient:

Reactions: Dyspnoea, C-Reactive Protein Increased, General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-01-26
    End date: 2012-07-18

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-01-26
    End date: 2012-07-18



Possible Dexamethasone side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient: 32 year old female

Reactions: Dyspnoea, Maternal Exposure During Pregnancy, Throat Tightness, Off Label Use, Caesarean Section, Premature Delivery, Blood Pressure Decreased, Oxygen Saturation Decreased, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bupivacaine Hydrochloride W / Epinephrine
    Dosage: 1.66 cc
    Indication: Spinal Anaesthesia

Cefazolin
    Indication: Prophylaxis

Cetirizine Hydrochloride
    Indication: Mastocytosis

Cetirizine Hydrochloride
    Indication: Prophylaxis

Dexamethasone
    Indication: Prophylaxis

Diphenhydramine HCL
    Indication: Prophylaxis

Fentanyl
    Indication: Spinal Anaesthesia

Phenylephrine HCL
    Indication: Caesarean Section

Sodium Citrate
    Dosage: 30 cc
    Administration route: Oral
    Indication: Prophylaxis



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: female

Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actos
    Dosage: 30 mg, qhs
    Indication: Diabetes Mellitus

Aredia
    Dosage: 90 mg, qmo over 4 hrs
    Indication: Multiple Myeloma
    Start date: 2001-10-01
    End date: 2002-01-01

Aredia
    Start date: 2008-07-07

Dexamethasone

Zometa
    Dosage: 4 mg, q2mo infusion over 25 mins every other month
    Indication: Multiple Myeloma
    End date: 2005-07-21

Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride



Possible Dexamethasone side effects in male

Reported by a physician from France on 2012-07-31

Patient: male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 900 mg, daily
    Indication: Lung Neoplasm Malignant
    Start date: 2012-03-05
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, unk
    Start date: 2012-03-05
    End date: 2012-05-15

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-03-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, unk
    Administration route: Oral
    Start date: 2012-03-03
    End date: 2012-03-15

Folic Acid
    Dosage: 0.4 mg, daily
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, bid

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-05
    End date: 2012-03-15

Ondansetron
    Dosage: 8 mg, unk
    Start date: 2012-03-03
    End date: 2012-03-15

Oxycodone Hydrochloride
    Dosage: 5 mg, prn
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Oxycontin
    Dosage: 90 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zometa
    Dosage: unk
    Start date: 2012-05-15
    End date: 2012-05-15



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31

Patient:

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 900 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Alimta
    Dosage: 900 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Alimta
    Dosage: 900 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Alimta
    Dosage: 900 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-03-04
    End date: 2012-03-06

Dexamethasone
    Dosage: 4 mg, bid
    Start date: 2012-04-16
    End date: 2012-04-16

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-05-16

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-03-26
    End date: 2012-03-28

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-05-15

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-05

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-03-27

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-04-17
    End date: 2012-04-17

Folic Acid
    Dosage: 0.4 mg, qd
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-06-04

Lyrica
    Dosage: 100 mg, bid
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Oxycontin
    Dosage: 90 mg, qd
    Administration route: Oral

Zometa
    Dosage: unk
    Start date: 2012-05-15
    End date: 2012-05-15

Other drugs received by patient: Oxycodone HCL; Cyanocobalamin



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Velcade
    End date: 2012-04-10

Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil



Possible Dexamethasone side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: 63 year old male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 900 mg, cyclic
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, cyclic
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05
    End date: 2012-05-15

Dexamethasone
    Dosage: 4 mg, 2x/day
    Administration route: Oral
    Start date: 2012-03-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, cyclic
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-05-15

Folic Acid
    Dosage: 0.4 mg, 1x/day
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, 2x/day
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, cyclic
    Start date: 2012-03-05
    End date: 2012-05-15

Ondansetron
    Dosage: 8 mg, cyclic
    Start date: 2012-03-05
    End date: 2012-05-15

Oxycontin
    Dosage: 40 mg in the morning and 50 mg in the evening
    Administration route: Oral

Zometa
    Dosage: unk
    Start date: 2012-05-15
    End date: 2012-05-15

Other drugs received by patient: Vitamin B-12; Oxyconorm



Possible Dexamethasone side effects in 78 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: 78 year old female, weighing 46.7 kg (102.7 pounds)

Reactions: Dyspnoea, Chest Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 32 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-23

Velcade
    Dosage: 1.5 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-03-19

Other drugs received by patient: Methadone Hydrochloride; Fluconazole; Metoclopramide; Vantin / 01043502 /; Losartan Potassium; Senna / 00142201 /; Valtrex; Norvasc; Miralax; Prilosec; Dilaudid; Magnesium Oxide



Possible Dexamethasone side effects in female

Reported by a physician from France on 2012-07-25

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.82 milligram;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Rituximab
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Treanda
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Other drugs received by patient: Pegfilgrastim



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24

Patient: male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-05-15

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-03-27

Alimta
    Dosage: 500 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-03-27

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-05-15

Cisplatin
    Dosage: 75 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Dexamethasone
    Dosage: 4 mg, bid
    Start date: 2012-04-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-27

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-05-15

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-05

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-04-17

Folic Acid
    Dosage: 0.4 mg, daily one week
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, bid
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-27

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-04-17

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-05

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-05-15

Ondansetron
    Dosage: 8 mg, daily

Oxycontin
    Dosage: 90 mg, daily

Zometa
    Start date: 2012-05-15

Other drugs received by patient: Oxycodone HCL; Vitamin B-12



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24

Patient: male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-05-15

Alimta
    Dosage: 500 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-03-27

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-05-15

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-03-27

Dexamethasone
    Dosage: 4 mg, bid
    Start date: 2012-04-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-05

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-27

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-04-17

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-05-15

Folic Acid
    Dosage: 0.4 mg, daily one week
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, bid
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-05

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-05-15

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-04-17

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-27

Ondansetron
    Dosage: 8 mg, daily

Oxycontin
    Dosage: 90 mg, daily

Zometa
    Start date: 2012-05-15

Other drugs received by patient: Oxycodone HCL; Vitamin B-12



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Dexamethasone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Dexamethasone side effects in

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient:

Reactions: Vomiting, Dyspnoea, Nausea, Pyrexia, Cardiomyopathy, Renal Failure Chronic, Weight Increased, Tumour Lysis Syndrome, Fatigue, Respiratory Failure, Vitamin B12 Deficiency, Alopecia, Ejection Fraction Decreased, Arteriosclerosis Coronary Artery, Respiratory Tract Infection, Cardiac Failure Congestive

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2007-11-05
    End date: 2007-12-03

Other drugs received by patient: OS-CAL / 00108001 /; Colace; Nexium; Synthroid; Allopurinol; Lasix; Lisinopril; Lovenox; Aspirin



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride



Possible Dexamethasone side effects in

Reported by a consumer/non-health professional from United States on 2012-07-09

Patient:

Reactions: Dyspnoea, Anaemia, General Physical Health Deterioration, Oesophageal Haemorrhage, Thrombocytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 8 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2010-08-30
    End date: 2011-11-04

Doxorubicin HCL
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-08-30
    End date: 2011-11-04

Velcade
    Dosage: 1.3 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-08-30
    End date: 2011-11-04

Other drugs received by patient: Moxonidin; Amlodipine; Finasterid Orion; Metoprolol Tartrate; Ramipril; Allopurinol; Levothyroxine Sodium; Calcivit D; Pantozol / 01263202 /; Hydromorphone HCL; Decostriol; Prednisone TAB; Tamsulosin HCL; Torsemide; Folsan



Possible Dexamethasone side effects in female

Reported by a physician from France on 2012-07-09

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.82 milligram;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-29

Rituximab
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-29

Treanda
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Other drugs received by patient: Pegfilgrastim



Possible Dexamethasone side effects in female

Reported by a lawyer from United States on 2012-07-02

Patient: female

Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Toxic Nodular Goitre, Left Ventricular Hypertrophy, Nasal Congestion, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Folliculitis, Fall, Gastric Ulcer, Hyperparathyroidism, Aortic Arteriosclerosis, Thyroid Mass, Perineurial Cyst, Depression, Renal Failure Acute, Decreased Appetite, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Pulmonary Valve Incompetence, Syncope, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Gait Disturbance, Dysaesthesia, Respiratory Tract Infection, Leukopenia, Weight Decreased, Vitamin D Deficiency, Goitre, Lower Limb Fracture, Herpes Zoster, Uterine Leiomyoma, Hypomagnesaemia, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Stomatitis, Chest Discomfort, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Sinusitis, RIB Fracture, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actos
    Dosage: 30 mg, qhs
    Indication: Diabetes Mellitus

Aredia
    Dosage: 90 mg, qmo over 4 hrs
    Indication: Multiple Myeloma
    Start date: 2001-10-01
    End date: 2002-01-01

Aredia
    Start date: 2008-07-07

Dexamethasone

Zometa
    Dosage: 4 mg, q2mo infusion over 25 mins every other month
    Indication: Multiple Myeloma
    End date: 2005-07-21

Other drugs received by patient: Xanax; Procrit / 00909301 /; Pentamidine Isethionate; Crestor; Enalapril Maleate; Magnesium Oxide; Vincristine + Adriamycin + Dexamethasone; Aspirin; Augmentin '125'; Benadryl; Decadron; Thalidomide; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Avalide; Potassium Chloride; Influenza Vaccine; Melphalan Hydrochloride; Metformin HCL; Doxil; Alkeran; Fortamet; Chemotherapeutics NOS; Hepatitis B Vaccine; Cyclophosphamide; Cytoxan; Pneumovax 23; Polio-Vaccine; Revlimid; Velcade; Prednisone TAB; Norvasc



Possible Dexamethasone side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-02

Patient: 42 year old male

Reactions: Dyspnoea

Drug(s) suspected as cause:
Chirocaine
    Indication: Analgesic Therapy

Dexamethasone
    Dosage: 8 mg
    Indication: Analgesic Therapy

Lidocaine
    Dosage: 1% 5ml/hour

Lidocaine
    Dosage: 1% 10ml/hour
    Indication: Analgesic Therapy



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-06-28

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim



Possible Dexamethasone side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28

Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)

Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure

Drug(s) suspected as cause:
(Domperidone)
    Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine Maleate
    Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg milligram(s) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg milligram(s) subcutaneous
    Indication: Chemotherapy

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    End date: 2011-07-05

Ranitidine
    Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: (Docusate); (Biotene / 00203502 / )



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28

Patient: male, weighing 97.6 kg (214.7 pounds)

Reactions: Cellulitis, Dyspnoea, Hypotension, Localised Oedema, Circulatory Collapse, Muscular Weakness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alemtuzumab

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Start date: 2012-04-16

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-04-30
    End date: 2012-05-24

Other drugs received by patient: Aspirin; Lansoprazole; Novorapid; Perindopril Erbumine; Simvastatin; Flucloxacillin; Allopurinol; Cotrim; Alendronate Sodium; Atenolol; Itraconazole; Lantus; Levothyroxine; Immune Globulin NOS; Acyclovir; Amitriptyline HCL



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-26

Patient: male, weighing 68.0 kg (149.7 pounds)

Reactions: Humerus Fracture, Small Intestinal Obstruction, Dyspnoea, Tendon Rupture, Sepsis, Urinary Retention

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone

Velcade
    Dosage: 2.3 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-02-14
    End date: 2011-02-24

Other drugs received by patient: Cymbalta; Percocet; Wellbutrin; Advair Diskus 100 / 50; Centrum Silver / 01292501 /; Clonazepam; Calcium with Vitamin D / 00944201 /; Nexium; Aspirin; Lunesta; Magnesium Sulfate; Crestor; Oxycontin; Senna / 00142201 /; Proventil / 00139501 /



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017